Conditional E.U. marketing authorization for Nexpovio in relapsed or refractory multiple myeloma March 30, 2021
European Commission approves Pemazyre for cholangiocarcinoma with FGFR2 fusion or rearrangement March 30, 2021
MTD of seliciclib defined at 400 mg for rheumatoid arthritis refractory to TNF blockade March 30, 2021
First subject dosed in phase I study of Gritstone's second-generation COVID-19 vaccine March 30, 2021
RSS